Nephroprotective effects with SGLT2i in CKD patients - PACE-CME

Nephroprotective effects with SGLTi in CKD patients

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Strong evidence for colchicine in patients with chronic coronary disease
Strong evidence for colchicine in patients with chronic coronary disease
ESC 2020
Strong evidence for colchicine in patients with chronic coronary disease
- Aernoud Fiolet, MD
- Aernoud Fiolet, MD, PhD
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
ESC 2020
No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19
- Prof. Renato D. Lopes, MD, PhD
Advantages of the digital 2020 ESC Congress
Advantages of the digital 2020 ESC Congress
ESC 2020
Advantages of the digital 2020 ESC Congress
- Prof. Barbara Casadei, MD
A step ahead in the management of HFmrEF and HFpEF
A step ahead in the management of HFmrEF and HFpEF
ESC 2020
A step ahead in the management of HFmrEF and HFpEF
- Prof. Burkert Pieske